Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ye Che

Showing results (71-80 of 77) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 77 results.
Journal of Medicinal Chemistry|November 7, 2014
Chemical and computational methods for the characterization of covalent reactive groups for the prospective design of irreversible inhibitorsMark E Flanagan, Joseph A Abramite, Dennis P Anderson, et al.
ACS Chemical Biology|July 9, 2016
Discovery of a Selective Covalent Inhibitor of Lysophospholipase-like 1 (LYPLAL1) as a Tool to Evaluate the Role of this Serine Hydrolase in MetabolismKay Ahn, Markus Boehm, Matthew F Brown, et al.
NPJ Vaccines|November 20, 2024
Preclinical characterization of the Omicron XBB.1.5-adapted BNT162b2 COVID-19 vaccineKayvon Modjarrad, Ye Che, Wei Chen, et al.
Journal of Medicinal Chemistry|January 20, 2012
Pyridone methylsulfone hydroxamate LpxC inhibitors for the treatment of serious gram-negative infectionsJustin I Montgomery, Matthew F Brown, Usa Reilly, et al.
Journal of Medicinal Chemistry|December 20, 2011
Potent inhibitors of LpxC for the treatment of Gram-negative infectionsMatthew F Brown, Usa Reilly, Joseph A Abramite, et al.
Angewandte Chemie (International Ed. in English)|June 30, 2016
Discovery of a Highly Selective Glycogen Synthase Kinase-3 Inhibitor (PF-04802367) That Modulates Tau Phosphorylation in the Brain: Translation for PET NeuroimagingSteven H Liang, Jinshan Michael Chen, Marc D Normandin, et al.
Nature|February 1, 2021
BNT162b vaccines protect rhesus macaques from SARS-CoV-2Annette B Vogel, Isis Kanevsky, Ye Che, et al.
Pageof 8

Showing results (71-80 of 77) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 77 results.
Journal of Medicinal Chemistry|November 7, 2014
Chemical and computational methods for the characterization of covalent reactive groups for the prospective design of irreversible inhibitorsMark E Flanagan, Joseph A Abramite, Dennis P Anderson, et al.
ACS Chemical Biology|July 9, 2016
Discovery of a Selective Covalent Inhibitor of Lysophospholipase-like 1 (LYPLAL1) as a Tool to Evaluate the Role of this Serine Hydrolase in MetabolismKay Ahn, Markus Boehm, Matthew F Brown, et al.
NPJ Vaccines|November 20, 2024
Preclinical characterization of the Omicron XBB.1.5-adapted BNT162b2 COVID-19 vaccineKayvon Modjarrad, Ye Che, Wei Chen, et al.
Journal of Medicinal Chemistry|January 20, 2012
Pyridone methylsulfone hydroxamate LpxC inhibitors for the treatment of serious gram-negative infectionsJustin I Montgomery, Matthew F Brown, Usa Reilly, et al.
Journal of Medicinal Chemistry|December 20, 2011
Potent inhibitors of LpxC for the treatment of Gram-negative infectionsMatthew F Brown, Usa Reilly, Joseph A Abramite, et al.
Angewandte Chemie (International Ed. in English)|June 30, 2016
Discovery of a Highly Selective Glycogen Synthase Kinase-3 Inhibitor (PF-04802367) That Modulates Tau Phosphorylation in the Brain: Translation for PET NeuroimagingSteven H Liang, Jinshan Michael Chen, Marc D Normandin, et al.
Nature|February 1, 2021
BNT162b vaccines protect rhesus macaques from SARS-CoV-2Annette B Vogel, Isis Kanevsky, Ye Che, et al.
Pageof 8